ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986

Committee Approves Concepts For Studies In Special Populations

December 11, 1987